MarketPulse

securities fraud

1001 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

monday.com Faces Class Action Over Alleged Growth Projection Misstatements

monday.com faces class action lawsuit alleging false growth projections during 2025-2026 period. Stock fell 21% after company abandoned $1.8B 2027 revenue target.
MNDYsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bernstein Liebhard Llp

Nektar Therapeutics Faces Securities Class Action Over Failed Trial Disclosures

Law firm Bernstein Liebhard announces class action against $NKTR over alleged misrepresentations regarding Phase 2b trial results, affecting investors from February to December 2025.
PLUGSLNONKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Boston Scientific Faces Securities Class Action Over False Electrophysiology Claims

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability and concealed adverse facts.
BSXEOSESLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Gossamer Bio Stock Crashes 80% After Failed Drug Trial, Triggering Securities Probe

Pomerantz LLP investigates Gossamer Bio after seralutinib Phase 3 trial failure triggers 80% stock crash, raising securities fraud concerns.
ALITCCGOSSsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

EPAM Systems Faces Securities Fraud Investigation After Major Customer Pullback

Pomerantz Law Firm investigates EPAM Systems for potential securities fraud after disclosure that largest customer NEORIS is reducing business, triggering 6.61% stock decline.
ALITCCEPAMsecurities fraudclass action lawsuit
BenzingaBenzinga··Schall Law Firm

Alight Stock Plummets 38% as Fraud Probe Launched Over Misleading Statements

Schall Law Firm probes Alight Inc. ($ALIT) for securities fraud following 38.2% stock plunge tied to Q4 2025 results showing gross profit and margin declines.
ALITsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Stellantis Faces Securities Probe After €22.2B Charge Triggers Sharp Stock Plunge

Law firm investigates Stellantis after €22.2 billion charge announcement causes 23.69% stock drop. Class action lawsuit being formed for affected investors.
STLAALITCCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Snowflake Faces Class Action Lawsuit Over $SNOW Stock Plunge Following Revenue Guidance Miss

Pomerantz Law Firm filed securities fraud lawsuit against Snowflake after February 2024 revenue warning triggered 18% stock decline. Investors can join until April 2026.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

AMC Class Action Over Excluded Dividend Reveals Securities Law Risks for Preferred Shareholders

Pomerantz Law Firm alleges AMC excluded APE preferred shareholders from special dividend through contractual loophole. Lead Plaintiff deadline: April 20, 2026.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Navan Faces Class Action Over IPO Disclosure Gaps as Pomerantz Targets Securities Violations

Pomerantz Law Firm filed class action lawsuit against Navan, alleging the company concealed 39% surge in sales/marketing expenses around October 2025 IPO.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Mereo BioPharma Stock Collapsed 87.7% After Trial Failure; Class Action Deadline Looms

Pomerantz Law Firm filed class action against $MREO after Phase 3 trial failures. Stock plummeted 87.7%. Investor deadline: April 6, 2026.
NAVNSNOWMREOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

PayPal Faces Class Action Lawsuit After Earnings Miss, CEO Exit, and Guidance Withdrawal

PayPal faces class action lawsuit following Q4 2025 earnings miss, CEO departure, and withdrawn 2027 guidance amid operational challenges.
SNOWPYPLNUVBsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Kaskela Law Firm

Law Firm Launches Securities Investigation into Reservoir Media and Two Other Companies

Kaskela Law Firm investigates Reservoir Media, Houlihan Lokey, and Kelly Services for potential securities violations and breach of fiduciary duty.
RSVRRSVRWHLIsecurities fraudfiduciary duty
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Boston Scientific Faces Securities Lawsuit Over Electrophysiology Market Misrepresentation

Boston Scientific faces class action lawsuit alleging misleading statements about electrophysiology market position, with stock down 17% after missing earnings guidance.
SNOWBSXDRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Nektar Therapeutics Faces Securities Fraud Class Action Over Failed Trial Disclosures

Schall Law Firm launches class action against $NKTR for alleged securities fraud tied to REZOLVE-AA trial protocol violations and misstatements between February-December 2025.
NKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Snowflake Hit With Class Action Over Undisclosed Product Changes, CEO Claims

Snowflake faces class action alleging company concealed material information about product changes harming revenue while making misleading positive statements through early 2024.
SNOWsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Ramaco Resources Hit With Class Action Over False Brook Mine Claims

Class action filed against Ramaco Resources ($METC) alleging executives made false statements about Brook Mine development progress, affecting investors from July-October 2025.
METCMETCBMETCIMETCZsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Apollo Global Management Faces Class Action Over Epstein Ties, Leadership Credibility in Question

Class action lawsuit filed against $APO alleging leadership made false statements about business dealings with Jeffrey Epstein, affecting securities purchased between May 2021-February 2026.
APOAPOSAPOpAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Mereo BioPharma Faces Class Action Over Failed Drug Trials and Misleading Statements

Mereo BioPharma faces class action over failed Phase 3 trials and alleged misleading statements. Investor deadline April 6, 2026.
MREOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Smart Digital Group Faces Major Class Action Over Market Manipulation, Insider Trading Allegations

Class action filed against $SDM alleging market manipulation, social media fraud, and insider share dumping. Investors who bought between May-September 2025 eligible to join.
SDMsecurities fraudclass action lawsuit